Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Abivax (ABVX) Interest & Investment Income: 2021-2024

Historic Interest & Investment Income for Abivax (ABVX) over the last 4 years, with Dec 2024 value amounting to $14.7 million.

  • Abivax's Interest & Investment Income rose 1.77% to $4.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $16.0 million, marking a year-over-year change of. This contributed to the annual value of $14.7 million for FY2024, which is 81.58% up from last year.
  • Abivax's Interest & Investment Income amounted to $14.7 million in FY2024, which was up 81.58% from $8.1 million recorded in FY2023.
  • In the past 5 years, Abivax's Interest & Investment Income registered a high of $14.7 million during FY2024, and its lowest value of $3.0 million during FY2021.
  • Moreover, its 3-year median value for Interest & Investment Income was $11.7 million (2022), whereas its average is $11.5 million.
  • In the last 5 years, Abivax's Interest & Investment Income surged by 294.66% in 2022 and then crashed by 31.03% in 2023.
  • Yearly analysis of 4 years shows Abivax's Interest & Investment Income stood at $3.0 million in 2021, then spiked by 294.66% to $11.7 million in 2022, then tumbled by 31.03% to $8.1 million in 2023, then skyrocketed by 81.58% to $14.7 million in 2024.